Replimune Group Inc

Healthcare · Biotechnology

12.40$ -1.9% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Replimune Group Inc (REPL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 252 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet REPL
Line item	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	23	–	–	68	65	59	154	152	154	144	151	250	234	330	314	559	543	524	503	485	461	459	436	679	647	604	562	533	488	535	498	604	551	470	389	334	332	252
Current Assets	22	21	–	68	65	55	152	145	141	128	118	191	174	268	252	499	484	465	444	428	404	402	379	624	593	550	508	479	434	480	443	548	496	413	334	280	279	201
Cash	21	-21	–	39	18	13	23	21	26	38	53	63	60	105	43	324	183	193	160	132	106	112	89	207	147	106	76	98	74	152	113	172	111	97	102	123	209	185
Cash & Short-Term Investments	21	21	–	65	62	52	148	142	135	121	110	181	169	262	245	493	476	458	436	420	396	395	372	616	583	539	497	466	421	469	432	537	484	403	324	269	269	195
Receivables	1.4	–	–	–	2.4	2.3	2.2	1.8	2.5	2.4	2.3	4.8	3.0	3.0	3.1	2.1	3.0	3.0	2.9	2.2	3.1	2.8	2.6	2.0	2.9	3.0	2.9	4.3	4.9	4.9	2.0	3.1	3.7	1.8	1.8	3.0	1.6	–
Inventory	–	–	–	–	-2.4	-2.3	-2.2	-1.8	-2.5	-2.4	-2.3	-4.8	-3.0	-3.0	-3.1	-2.1	–	–	–	–	–	-2.8	–	–	–	–	–	–	–	-0.4	–	–	–	–	–	–	–	–
Property, Plant & Equipment	0.3	–	–	–	0.4	0.4	0.4	6.1	12	1.7	16	58	58	60	7.2	7.2	7.4	57	7.2	7.4	56	8.3	7.9	7.7	–	7.6	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	–	–	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	–	–	–	–	–	0.0	0.0	–	–	0.6	1.2	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	2.0	–	–	2.3	93	98	3.8	8.9	16	13	31	53	50	52	53	43	44	45	46	48	50	49	52	83	91	90	97	111	113	109	117	121	135	133	126	123	166	147
Current Liabilities	2.0	–	–	2.3	5.2	4.5	3.7	3.8	9.9	13	12	14	12	12	13	13	15	15	17	18	21	20	24	26	34	32	40	39	40	36	44	48	62	60	53	50	58	38
Short-Term Debt	–	–	–	–	–	–	–	–	–	0.4	0.7	3.4	3.3	3.3	3.3	3.4	3.5	3.5	3.5	3.6	3.6	3.6	3.6	3.7	3.8	3.8	3.8	3.9	3.9	3.9	4.0	3.9	4.0	4.0	4.1	4.1	4.0	4.0
Accounts Payable	0.3	–	–	0.5	2.0	2.9	2.1	1.5	7.1	11	8.0	6.3	3.4	3.5	2.4	2.4	2.4	2.4	3.2	3.9	3.7	4.5	4.0	3.6	5.4	4.9	4.4	3.9	2.6	0.9	8.4	7.2	12	15	6.4	5.6	6.7	4.3
Long-Term Debt	–	–	–	–	–	0.0	0.0	5.0	6.6	–	9.7	9.7	9.8	9.8	9.8	–	–	–	–	–	–	–	–	28	29	29	29	44	45	45	46	46	46	47	47	48	83	84
Shareholders' Equity	21	21	–	66	-28	-39	150	143	138	130	121	198	184	278	261	516	499	479	457	438	411	410	384	595	555	514	465	422	375	426	381	482	416	337	263	211	166	106
Retained Earnings	-9.2	–	–	-22	-29	-39	-45	-53	-60	-69	-80	-97	-112	-130	-150	-172	-193	-220	-250	-280	-311	-353	-397	-436	-485	-535	-595	-646	-701	-755	-808	-874	-949	-1,035	-1,118	-1,189	-1,263	-1,332
Shares Outstanding	31	31	31	31	31	31	25	32	31	32	32	35	39	40	44	49	47	52	52	52	47	54	55	58	57	66	67	67	61	69	79	83	81	92	92	92	93	97

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings